Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αVβ3-Integrin Ligands for Tumor Targeting

Paula López Rivas, Ivan Ranđelović, André Raposo Moreira Dias, Arianna Pina, Daniela Arosio, J. Tóvári, G. Mező, Alberto Dal Corso, Luca Pignataro, Cesare Gennari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Two cyclo[DKP-RGD]-PTX (PTX = paclitaxel) and two cyclo[RGDfK]-PTX conjugates containing the Gly-Phe-Leu-Gly (GFLG) linker, which is cleavable by lysosomal enzymes, were synthesized and compared to two cyclo[DKP-RGD]-Val-Ala-PTX conjugates. The conjugates were evaluated for their ability to inhibit biotinylated vitronectin binding to the isolated αvβ3 receptor, retaining good binding affinity, in the same nanomolar range of the free ligands. Cell viability assays were performed for the six conjugates in the αvβ3+ U87 and in the αvβ3– HT29 cell lines. Loss of potency was observed for all the conjugates, attenuated by the presence of a tetraethylene glycol (PEG-4) spacer. A good Targeting Index (TI = Relative Potency in the αvβ3+ U87/Relative Potency in the αvβ3– HT29) was displayed by the conjugates, in particular by cyclo[DKP-RGD]-PEG-4-Val-Ala-PTX 9 (TI = 533). This conjugate was tested in the αvβ3+ U87 cell line in the presence of 50-fold excess free cyclo[DKP-RGD] ligand 2. In this competition experiment, a fivefold decrease of the conjugate cytotoxicity was calculated, suggesting that the conjugate is possibly internalized by an αvβ3 integrin-mediated process.

Original languageEnglish
Pages (from-to)2902-2909
Number of pages8
JournalEuropean Journal of Organic Chemistry
Volume2018
Issue number23
DOIs
Publication statusPublished - Jun 22 2018

Fingerprint

Paclitaxel
Integrins
enzymes
Tumors
tumors
Cells
Ligands
ligands
Polyethylene glycols
evaluation
Enzymes
synthesis
Vitronectin
Glycols
Cytotoxicity
Assays
cultured cells
Experiments
retaining
viability

Keywords

  • Antitumor agents
  • Drug delivery
  • Integrins
  • Linker technology
  • Peptidomimetics

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αVβ3-Integrin Ligands for Tumor Targeting. / López Rivas, Paula; Ranđelović, Ivan; Raposo Moreira Dias, André; Pina, Arianna; Arosio, Daniela; Tóvári, J.; Mező, G.; Dal Corso, Alberto; Pignataro, Luca; Gennari, Cesare.

In: European Journal of Organic Chemistry, Vol. 2018, No. 23, 22.06.2018, p. 2902-2909.

Research output: Contribution to journalArticle

López Rivas, Paula ; Ranđelović, Ivan ; Raposo Moreira Dias, André ; Pina, Arianna ; Arosio, Daniela ; Tóvári, J. ; Mező, G. ; Dal Corso, Alberto ; Pignataro, Luca ; Gennari, Cesare. / Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αVβ3-Integrin Ligands for Tumor Targeting. In: European Journal of Organic Chemistry. 2018 ; Vol. 2018, No. 23. pp. 2902-2909.
@article{b5a1028f44b24f5b8bac5e1f2683a1a6,
title = "Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αVβ3-Integrin Ligands for Tumor Targeting",
abstract = "Two cyclo[DKP-RGD]-PTX (PTX = paclitaxel) and two cyclo[RGDfK]-PTX conjugates containing the Gly-Phe-Leu-Gly (GFLG) linker, which is cleavable by lysosomal enzymes, were synthesized and compared to two cyclo[DKP-RGD]-Val-Ala-PTX conjugates. The conjugates were evaluated for their ability to inhibit biotinylated vitronectin binding to the isolated αvβ3 receptor, retaining good binding affinity, in the same nanomolar range of the free ligands. Cell viability assays were performed for the six conjugates in the αvβ3+ U87 and in the αvβ3– HT29 cell lines. Loss of potency was observed for all the conjugates, attenuated by the presence of a tetraethylene glycol (PEG-4) spacer. A good Targeting Index (TI = Relative Potency in the αvβ3+ U87/Relative Potency in the αvβ3– HT29) was displayed by the conjugates, in particular by cyclo[DKP-RGD]-PEG-4-Val-Ala-PTX 9 (TI = 533). This conjugate was tested in the αvβ3+ U87 cell line in the presence of 50-fold excess free cyclo[DKP-RGD] ligand 2. In this competition experiment, a fivefold decrease of the conjugate cytotoxicity was calculated, suggesting that the conjugate is possibly internalized by an αvβ3 integrin-mediated process.",
keywords = "Antitumor agents, Drug delivery, Integrins, Linker technology, Peptidomimetics",
author = "{L{\'o}pez Rivas}, Paula and Ivan Ranđelović and {Raposo Moreira Dias}, Andr{\'e} and Arianna Pina and Daniela Arosio and J. T{\'o}v{\'a}ri and G. Mező and {Dal Corso}, Alberto and Luca Pignataro and Cesare Gennari",
year = "2018",
month = "6",
day = "22",
doi = "10.1002/ejoc.201800447",
language = "English",
volume = "2018",
pages = "2902--2909",
journal = "European Journal of Organic Chemistry",
issn = "1434-193X",
publisher = "Wiley-VCH Verlag",
number = "23",

}

TY - JOUR

T1 - Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αVβ3-Integrin Ligands for Tumor Targeting

AU - López Rivas, Paula

AU - Ranđelović, Ivan

AU - Raposo Moreira Dias, André

AU - Pina, Arianna

AU - Arosio, Daniela

AU - Tóvári, J.

AU - Mező, G.

AU - Dal Corso, Alberto

AU - Pignataro, Luca

AU - Gennari, Cesare

PY - 2018/6/22

Y1 - 2018/6/22

N2 - Two cyclo[DKP-RGD]-PTX (PTX = paclitaxel) and two cyclo[RGDfK]-PTX conjugates containing the Gly-Phe-Leu-Gly (GFLG) linker, which is cleavable by lysosomal enzymes, were synthesized and compared to two cyclo[DKP-RGD]-Val-Ala-PTX conjugates. The conjugates were evaluated for their ability to inhibit biotinylated vitronectin binding to the isolated αvβ3 receptor, retaining good binding affinity, in the same nanomolar range of the free ligands. Cell viability assays were performed for the six conjugates in the αvβ3+ U87 and in the αvβ3– HT29 cell lines. Loss of potency was observed for all the conjugates, attenuated by the presence of a tetraethylene glycol (PEG-4) spacer. A good Targeting Index (TI = Relative Potency in the αvβ3+ U87/Relative Potency in the αvβ3– HT29) was displayed by the conjugates, in particular by cyclo[DKP-RGD]-PEG-4-Val-Ala-PTX 9 (TI = 533). This conjugate was tested in the αvβ3+ U87 cell line in the presence of 50-fold excess free cyclo[DKP-RGD] ligand 2. In this competition experiment, a fivefold decrease of the conjugate cytotoxicity was calculated, suggesting that the conjugate is possibly internalized by an αvβ3 integrin-mediated process.

AB - Two cyclo[DKP-RGD]-PTX (PTX = paclitaxel) and two cyclo[RGDfK]-PTX conjugates containing the Gly-Phe-Leu-Gly (GFLG) linker, which is cleavable by lysosomal enzymes, were synthesized and compared to two cyclo[DKP-RGD]-Val-Ala-PTX conjugates. The conjugates were evaluated for their ability to inhibit biotinylated vitronectin binding to the isolated αvβ3 receptor, retaining good binding affinity, in the same nanomolar range of the free ligands. Cell viability assays were performed for the six conjugates in the αvβ3+ U87 and in the αvβ3– HT29 cell lines. Loss of potency was observed for all the conjugates, attenuated by the presence of a tetraethylene glycol (PEG-4) spacer. A good Targeting Index (TI = Relative Potency in the αvβ3+ U87/Relative Potency in the αvβ3– HT29) was displayed by the conjugates, in particular by cyclo[DKP-RGD]-PEG-4-Val-Ala-PTX 9 (TI = 533). This conjugate was tested in the αvβ3+ U87 cell line in the presence of 50-fold excess free cyclo[DKP-RGD] ligand 2. In this competition experiment, a fivefold decrease of the conjugate cytotoxicity was calculated, suggesting that the conjugate is possibly internalized by an αvβ3 integrin-mediated process.

KW - Antitumor agents

KW - Drug delivery

KW - Integrins

KW - Linker technology

KW - Peptidomimetics

UR - http://www.scopus.com/inward/record.url?scp=85048940371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048940371&partnerID=8YFLogxK

U2 - 10.1002/ejoc.201800447

DO - 10.1002/ejoc.201800447

M3 - Article

VL - 2018

SP - 2902

EP - 2909

JO - European Journal of Organic Chemistry

JF - European Journal of Organic Chemistry

SN - 1434-193X

IS - 23

ER -